ACADIA Pharmaceuticals
ACAD
#3212
Rank
$4.59 B
Marketcap
$27.15
Share price
1.76%
Change (1 day)
57.30%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Cash on Hand

Cash on Hand as of September 2025 : $0.84 Billion USD

According to ACADIA Pharmaceuticals's latest financial reports the company has $0.84 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ACADIA Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.75 B72.26%
2023-12-31$0.43 B5.29%
2022-12-31$0.41 B-19.95%
2021-12-31$0.52 B-17.6%
2020-12-31$0.63 B-9.39%
2019-12-31$0.69 B47.29%
2018-12-31$0.47 B38.72%
2017-12-31$0.34 B-35.48%
2016-12-31$0.52 B145.91%
2015-12-31$0.21 B-33.29%
2014-12-31$0.32 B73.58%
2013-12-31$0.18 B72.08%
2012-12-31$0.10 B247.74%
2011-12-31$31.04 M-16.28%
2010-12-31$37.08 M-21.19%
2009-12-31$47.06 M-21.68%
2008-12-31$60.08 M-52.64%
2007-12-31$0.12 B52.37%
2006-12-31$83.25 M93.61%
2005-12-31$43 M19.69%
2004-12-31$35.92 M32.02%
2003-12-31$27.21 M118.78%
2002-12-31$12.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Vanda Pharmaceuticals
VNDA
$0.29 B-65.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$14.98 B 1,669.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$9.91 B 1,070.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$18.56 B 2,091.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$16.50 B 1,848.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA